
Sign up to save your podcasts
Or


Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
CME information and select publications here.

134 Listeners

321 Listeners

504 Listeners

65 Listeners

30 Listeners

75 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

59 Listeners

3,374 Listeners

203 Listeners

46 Listeners

23 Listeners

367 Listeners

195 Listeners

45 Listeners

0 Listeners